Improving Outcomes After Relapse in Ewing's Sarcoma: Analysis of 114 Patients From a Single Institution (Q27496197)

1

0 references

Anna M Cassoni

2

0 references

Deirdre Driver

3

0 references

Maria P Michelagnoli

4

0 references

Anne M Kilby

5

0 references

Jeremy S Whelan

6

0 references

Anne M. McTiernan

1

0 references

Anna M. Cassoni

2

0 references

Maria P. Michelagnoli

4

0 references

Anne M. Kilby

5

0 references

Jeremy S. Whelan

Creative Commons Attribution 3.0 Unported

6

0 references

language of work or name

English

0 references

publication date

2006

0 references

1 reference

2006

0 references

page(s)

83548

0 references

1-8

0 references

copyright license

start time

1 January 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Survival after recurrence of Ewing's sarcoma family of tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1698143

A systematic review of the role of pulmonary irradiation in the management of primary bone tumours

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1698143

Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1698143

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1698143

Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1698143

Long-term survival in patients with Ewing's sarcoma relapsing after completing therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1698143

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1698143

Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.

2 June 2018

1 reference

https://api.crossref.org/works/10.1155%2FSRCM%2F2006%2F83548

Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2FSRCM%2F2006%2F83548

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2FSRCM%2F2006%2F83548

Carboplatin-based chemotherapy for refractory and recurrent Ewing's tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2FSRCM%2F2006%2F83548

Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2FSRCM%2F2006%2F83548

Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2FSRCM%2F2006%2F83548

Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2FSRCM%2F2006%2F83548

Therapy and survival after recurrence of Ewing’s tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1698143

Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999

27 November 2018

1 reference

12 December 2020

Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies

1 reference

12 December 2020

Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG)

1 reference

12 December 2020

[High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS]

1 reference

12 December 2020

Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party

1 reference

12 December 2020

Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study

1 reference

12 December 2020